Cagrilintide
Price range: £32.00 through £52.00
Strengths Available: 5mg / 10mg
Format: Sealed containment / vial presentations available
Volume: 3mL
What is Cagrilintide about?
Cagrilintide is a research-grade peptide studied in the context of metabolic signalling, energy balance, and related receptor pathways. Investigators have explored how Cagrilintide interacts with pathways relevant to glucose handling, appetite regulation, or lipid metabolism in laboratory models.
Description
What is Cagrilintide?
Cagrilintide is frequently referenced in research focused on metabolic regulation, energy balance, and body-composition science. It has attracted scientific attention as a research tool for exploring how metabolic and appetite-signalling pathways are regulated. Cagrilintide is a research-grade peptide studied in the context of metabolic signalling, energy balance, and related receptor pathways. Investigators have explored how Cagrilintide interacts with pathways relevant to glucose handling, appetite regulation, or lipid metabolism in laboratory models.
Why Cagrilintide Attracted Research Interest
Researchers became interested in Cagrilintide because of its relevance to metabolic regulation and the study of energy-balance pathways. It provides a defined research tool for examining metabolic signalling in experimental models.
Key Research Focus Areas
- Metabolic and energy-balance signalling models
- Glucose and lipid metabolism research
- Appetite and satiety pathway studies
- Receptor-binding and pathway investigations
- Body-composition research models
- Mitochondrial and cellular-energy research
What the Research Has Shown
In preclinical research, Cagrilintide has been studied for its influence on metabolic signalling and energy balance pathways. Mechanistic studies have explored its interaction with receptors and pathways central to metabolic regulation.
Scientific Background and Research Context of Cagrilintide
Cagrilintide is a long-acting synthetic analogue of amylin, a peptide hormone naturally co-secreted with insulin by pancreatic beta cells. Amylin is involved in appetite regulation, satiety signalling, gastric emptying, and post-meal glucose control. Cagrilintide was developed to mimic amylin activity while extending its duration of action, making it scientifically relevant in metabolic, obesity, and body-composition research.
Cagrilintide attracted attention because the amylin pathway is distinct from, but complementary to, the GLP-1 pathway. While GLP-1 receptor agonists such as semaglutide are widely studied for incretin and appetite-related effects, amylin analogues are being explored for their ability to influence satiety through both homeostatic and reward-related brain regions. This makes cagrilintide an important research compound for studying energy intake, appetite control, and weight-regulation biology.
Exploring the Science Behind Amylin
Amylin is released after nutrient intake and helps regulate meal size by promoting satiety and slowing gastric emptying. In research, amylin receptor activation is associated with reduced food intake and body-weight effects. Cagrilintide, also known in earlier research as AM833, is described as an investigational long-acting acylated amylin analogue that acts as a non-selective amylin receptor agonist.
Research Context in Metabolic and Body-Composition Science
Cagrilintide has been studied both as a standalone amylin analogue and in combination with semaglutide. The combination, often referred to as CagriSema, is being investigated because GLP-1 and amylin signalling may provide complementary effects on appetite, satiety, food intake, and metabolic outcomes. A 2024 review described cagrilintide as an amylin analogue being developed with semaglutide to support sustained weight-loss research in people with overweight and obesity.
Research interest also includes comparing cagrilintide with GLP-1 receptor agonists and studying whether amylin-based approaches may offer different tolerability or appetite-regulation profiles. A 2024 systematic review reported that CagriSema outperformed semaglutide for weight-loss outcomes in the analysed studies, while cagrilintide alone showed comparable weight-loss effects to semaglutide/liraglutide in some comparisons.
Ongoing Scientific Interest
Cagrilintide remains an active area of investigation because it represents a newer direction in metabolic research: targeting amylin biology alongside incretin pathways. Current research is focused on how amylin receptor activation may influence food intake, satiety, gastric emptying, body weight, glucose regulation, and long-term cardiometabolic outcomes.
Cagrilintide is best understood as a research peptide connected to amylin signalling, appetite regulation, obesity science, and body-composition research. It is investigational and, where sold for laboratory purposes, should be positioned clearly as a research compound rather than a medical treatment.
For research and laboratory use only. Not for human or veterinary use.
Ingredient Profile
Single research compound: Cagrilintide. CAS: —. Purity >99%. Supplied as lyophilised powder (no excipients, fillers or additives).
Active Ingredients
Cagrilintide — 10mg
Ingredient Breakdown
Cagrilintide: 10mg of active peptide per vial (lyophilised).
Why is Cagrilintide studied in metabolic research?
Because studies have explored its relevance to metabolic regulation and energy-balance pathways.
Is Cagrilintide approved for medical use?
No. It is supplied strictly for research and laboratory use only, and is not intended for human or veterinary use.
Why does purity matter so much for this product?
High purity helps ensure that observed research effects are due to the material itself rather than impurities.
What does ‘research grade’ mean?
It means the product is supplied with documentation and traceability for laboratory investigation.
Is international supply available?
Yes. International fulfilment and temperature controlled shipping can be supported where appropriate.
Research & laboratory use only. Not for human or veterinary use. Not a medicinal product, supplement, food or medical device. No therapeutic, diagnostic, cosmetic, wellness or lifestyle claims are made or implied. Analytical reference/click information is a laboratory measurement aid only and must not be applied to living systems.
Typically supplied at >99% purity, supported by batch-specific analytical data. UK-based preparation, analysis and release under scientist-led, GMP-aligned processes with full batch-level traceability. Certificate of Analysis (CoA) available on request; independent analytical verification where appropriate.
Store the lyophilised powder refrigerated at 2–8°C, protected from light and moisture; suitable for longer-term storage frozen at -20°C. Handle under appropriate laboratory conditions. For in vitro research use only.
For in vitro laboratory research only. Reconstitution, handling and experimental design at the discretion of the qualified researcher. The 300-click sealed-containment system is an analytical measurement reference only and does not represent dosing or administration guidance. Not for use in living systems.
Partner with FreshstartPharma– Where Accuracy Meets Innovation
Freshstartpharma is committed to delivering high-quality research-grade products designed for advanced scientific applications. We offer wholesale partnerships to selected businesses that share our values of integrity, quality, and innovation. Whether you’re an established distributor or an emerging research supply company, we invite you to join our network and benefit from exclusive access to our state-of-the-art product range.
Related Products
Ipamorelin
GHK-Cu
ARA-290 (Cibinetide)
